10-K Filing

LIMBACH HOLDINGS, INC. CIK: 1606163 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001144204-15-015101`
Period End Date	20141231
Filing Date	20150310
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	tfscu-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 27 Income Statement 8 Cash Flow Statement 20 Stockholders Equity 14

Balance Sheet 27 line items

Line Item	Tag	Value	Unit	Period
Common stock redemption amount shares	`TemporaryEquitySharesOutstanding`	4.10M	shares	Point-in-time
Common stock redemption per share	`TemporaryEquityRedemptionPricePerShare`	$10.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$397.39K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$72.48K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total assets	`AssetsCurrent`	$469.87K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and investments held in trust account	`AssetsHeldInTrustNoncurrent`	$46.01M	USD	Point-in-time
Total Assets	`Assets`	$46.48M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	1.85M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	1.85M	shares	Point-in-time
Accounts payable & accrued expenses	`AccountsPayableCurrent`	$69.85K	USD	Point-in-time
Note payable to stockholder	`DueToOfficersOrStockholdersCurrent`	$125.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$194.85K	USD	Point-in-time
Common Stock subject to possible redemption; 4,099,999 shares at approximately $10 per share	`TemporaryEquityCarryingAmountAttributableToParent`	$41.00M	USD	Point-in-time
Preferred stock, $.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.0001 par value; 10,000,000 shares authorized; 1,848,001 issued and outstanding	`CommonStockValue`	$185.00	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.47M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$189.75K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$5.28M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$46.48M	USD	Point-in-time

Income Statement 8 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueNet`	-	USD	3 Qtrs
Formation costs	`OperatingExpenses`	$565.00	USD	3 Qtrs
General and administrative costs	`GeneralAndAdministrativeExpense`	$197.74K	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-198.30K	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$8.55K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-189.75K	USD	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.58M	shares	3 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	3 Qtrs

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Investment Warrants, Exercise Price	`InvestmentWarrantsExercisePrice`	$15.00	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-189.75K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$69.85K	USD	3 Qtrs
Prepaid assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$72.48K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-192.38K	USD	3 Qtrs
Investment in restricted cash and investments	`IncreaseDecreaseInRestrictedCashAndInvestments`	$46.01M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-46.01M	USD	3 Qtrs
Proceeds from sale of shares of common stock to initial stockholder	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	3 Qtrs
Proceeds from note payable - stockholder	`ProceedsFromNotesPayable`	$125.00K	USD	3 Qtrs
Proceeds from sale of units in IPO, including over-allotment, net of offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$44.17M	USD	3 Qtrs
Proceeds from private placement of units, including over-allotment	`ProceedsFromIssuanceOfPrivatePlacement`	$1.98M	USD	3 Qtrs
Proceeds from private placement of $15 exercise price warrants	`ProceedsFromIssuanceOfPrivatePlacementExercisePriceOfWarrants`	$300.00K	USD	3 Qtrs
Proceeds from sale of underwritter purchase option	`ProceedsFromStockOptionsExercised`	$100.00	USD	3 Qtrs
Deferred costs associated with initial public offering	`PaymentsForRepurchaseOfInitialPublicOffering`	-	USD	3 Qtrs
Net Cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$46.60M	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$397.39K	USD	3 Qtrs
Cash at beginning of period	`Cash`	-	USD	Point-in-time
Cash at beginning of period	`Cash`	$397.39K	USD	Point-in-time
Cash at end of period	`Cash`	-	USD	Point-in-time
Cash at end of period	`Cash`	$397.39K	USD	Point-in-time

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	-	USD	Point-in-time
Balance	`StockholdersEquity`	$5.28M	USD	Point-in-time
Investment Warrants, Exercise Price	`InvestmentWarrantsExercisePrice`	$15.00	USD	3 Qtrs
Common shares issued to initial stockholders	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	3 Qtrs
Common shares issued to initial stockholders (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	4.00M	shares	Point-in-time
Common shares issued to initial stockholders (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.15M	shares	Point-in-time
Sale of 4,600,000 units at $10 per unit in IPO, including over-allotment, net of underwriters' discount and offering expenses	`StockIssuedDuringPeriodValueIssuedForServices`	$44.17M	USD	3 Qtrs
Sale of 198,000 units at $10 per unit in private placement, including over-allotment	`StockIssuedDuringPeriodValueOther`	$1.98M	USD	3 Qtrs
Sale of 600,000 $15 exercise price warrants at $0.5 per warrant in private placement	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$300.00K	USD	3 Qtrs
Issuance of underwritter purchase option	`AdjustmentsToAdditionalPaidInCapitalOther`	$100.00	USD	3 Qtrs
Common shares subject to possible redemption	`StockRedeemedOrCalledDuringPeriodValue`	$41.00M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-189.75K	USD	3 Qtrs
Balance	`StockholdersEquity`	-	USD	Point-in-time
Balance	`StockholdersEquity`	$5.28M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.